SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-235793
Filing Date
2019-09-03
Accepted
2019-09-03 07:05:03
Documents
1
Period of Report
2019-09-03
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d792131d8k.htm 8-K 18088
  Complete submission text file 0001193125-19-235793.txt   19339
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 191070837
SIC: 2834 Pharmaceutical Preparations